Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Expert Opin Ther Pat. 2015 Mar 15;25(7):837–844. doi: 10.1517/13543776.2015.1025752

Figure 4.

Figure 4

Lead EP2 antagonists currently available for in vivo use. EP2 Schild KB (derived from a cAMP-mediated-TR-FRET assay) and pharmacokinetics are shown in inset box. Blue boxes are used to indicate the similarity.